Comparison between ABH Healthcare IPO and Invicta Diagnostic IPO.
ABH Healthcare IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Invicta Diagnostic IPO is a SME Bookbuilding proposed to list at NSE SME.
| ABH Healthcare IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fedex Securities Pvt.Ltd. | Socradamus Capital Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of ABH Healthcare IPO is up to ₹0.00 Cr whereas the issue size of the Invicta Diagnostic IPO is up to ₹26.71 Cr. The final issue price of ABH Healthcare IPO is and of Invicta Diagnostic IPO is ₹85.00 per share.
| ABH Healthcare IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹85.00 per share | |
| Issue Price (Final) | ₹85.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | |
| Fresh Issue Size | 34,29,000 shares | 31,42,400 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹26.71 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,29,000 shares | 31,42,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹26.71 Cr |
ABH Healthcare IPO opens on , while Invicta Diagnostic IPO opens on Dec 01, 2025. The closing date of ABH Healthcare IPO and Invicta Diagnostic IPO is , and Dec 03, 2025, respectively.
| ABH Healthcare IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2025 | |
| Issue Open | Dec 01, 2025 | |
| Issue Close | Dec 03, 2025 | |
| Basis Of Allotment (Tentative) | Dec 04, 2025 | |
| Initiation of Refunds (Tentative) | Dec 05, 2025 | |
| Credit of Share (Tentative) | Dec 05, 2025 | |
| Listing date (Tentative) | Dec 08, 2025 | |
| Anchor Lockin End date 1 | Jan 02, 2026 | |
| Anchor Lockin End date 2 | Mar 03, 2026 |
ABH Healthcare IPO P/E ratio is , as compared to Invicta Diagnostic IPO P/E ratio of 14.51.
| ABH Healthcare IPO | Invicta Diagnostic IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 90.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.69 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹106.86 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 30.33% | 44.28% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.96% | 42.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.69 | 0.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.33% | 36.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ABH Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in Invicta Diagnostic IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in ABH Healthcare IPO and 5,34,400 shares in Invicta Diagnostic IPO.
| ABH Healthcare IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 7,98,400 shares |
| Market Maker Reservation | 0 shares | 1,66,400 shares |
| QIB | 0 shares | 5,34,400 shares |
| NII | 0 shares | 5,42,400 shares |
| RII | 0 shares | 12,67,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 31,42,400 shares |
ABH Healthcare IPO subscribed in total, whereas Invicta Diagnostic IPO subscribed 4.27x.
| ABH Healthcare IPO | Invicta Diagnostic IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 6.96x | |
| Big NII (times) | 7.30x | |
| Small NII (times) | 6.27x | |
| RII (times) | 3.44x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.27x |
